BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abe T, Sasaki A, Ueda T, Miyakawa Y, Ochiai H. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report. Medicine (Baltimore) 2017;96:e6056. [PMID: 28178155 DOI: 10.1097/MD.0000000000006056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Sakurai S, Kato H, Yoshida Y, Sugawara Y, Fujisawa M, Yasumoto A, Matsumoto M, Fujimura Y, Yatomi Y, Nangaku M. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase. J Atheroscler Thromb 2020;27:353-62. [PMID: 31484852 DOI: 10.5551/jat.49494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Hoevenaar M, Goossens D, Roorda J. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320979097. [PMID: 33283602 DOI: 10.1177/1470320320979097] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fletcher-Sandersjöö A, Bellander BM. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res 2020;194:36-41. [PMID: 32569879 DOI: 10.1016/j.thromres.2020.06.027] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
4 Kawano N, Abe T, Ikeda N, Nagahiro Y, Kawano S, Tochigi T, Nakaike T, Yamashita K, Kubo K, Yamanaka A, Terasaka S, Marutsuka K, Mashiba K, Kikuchi I, Shimoda K, Matsumoto M, Ochiai H. Clinical features and outcomes of four atypical hemolytic uremic syndrome cases at a single institution in Miyazaki Prefecture from 2015 to 2019. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00396-6] [Reference Citation Analysis]
5 Lester R, Church D, Ambasta A. Disseminated cerebral aspergillosis complicated by thrombotic microangiopathy. Med Mycol Case Rep 2019;25:25-8. [PMID: 31334000 DOI: 10.1016/j.mmcr.2019.07.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Fletcher-Sandersjöö A, Maegele M, Bellander BM. Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol. Int J Mol Sci 2020;21:E1596. [PMID: 32111078 DOI: 10.3390/ijms21051596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fodil S, Annane D. Complement Inhibition and COVID-19: The Story so Far. Immunotargets Ther 2021;10:273-84. [PMID: 34345614 DOI: 10.2147/ITT.S284830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]